Literature DB >> 7904272

Effects of single dose compared with three days' prednisolone treatment of healthy volunteers: contrasting effects on circulating lymphocyte subsets.

G D Pountain1, M T Keogan, B L Hazleman, D L Brown.   

Abstract

AIMS: To investigate the effects of longer term corticosteroid treatment on circulating lymphocyte subsets.
METHODS: Prednisolone (20 mg daily) was given to 12 healthy volunteers in a single morning dose for three days. Circulating lymphocyte subsets were measured by flow cytometry after whole blood lysis.
RESULTS: Seven hours after the first dose of prednisolone there was a significant fall in absolute numbers of lymphocytes, T cells, CD4+ and CD8+ cells, and B cells. The percentage of T cells fell significantly, due to a fall in percentage of CD4+ cells. In contrast to the seven hour findings, at 72 hours there was a significant rise in absolute numbers of lymphocytes, T cells, CD4+, CD8+, and B cells. This trend was already apparent by 24 hours. The percentage of CD4+ cells was significantly raised at 72 hours, while that of CD8+ cells had fallen significantly. The percentage of natural killer cells had fallen at 72 hours; that of B cells remained increased at 72 hours.
CONCLUSIONS: These findings show that corticosteroid treatment causes significant changes in lymphocyte subsets, and that such changes must be considered when designing studies of lymphocyte subsets during illness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904272      PMCID: PMC501716          DOI: 10.1136/jcp.46.12.1089

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Human lymphocyte subpopulations. Effect of corticosteroids.

Authors:  D T Yu; P J Clements; H E Paulus; J B Peter; J Levy; E V Barnett
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  Glucocorticoid receptors and glucocorticoid sensitivity of mitogen stimulated and unstimulated human lymphocytes.

Authors:  K A Smith; G R Crabtree; S J Kennedy; A U Munck
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

3.  T lymphocytes and plasma inhibitory factor in ACTH-dependent Cushing's patients.

Authors:  B Shohat; A Klein; H Kaufmann; I Blum; I Chowers
Journal:  Clin Immunol Immunopathol       Date:  1979-08

4.  Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.

Authors:  G D Pountain; M T Keogan; D L Brown; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

5.  Enumeration of T lymphocyte subsets by monoclonal antibodies in young and aged humans.

Authors:  J E Nagel; F J Chrest; W H Adler
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

6.  Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function.

Authors:  A S Fauci
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

7.  Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow.

Authors:  A S Fauci
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

8.  Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes.

Authors:  R J ten Berge; H P Sauerwein; S L Yong; P T Schellekens
Journal:  Clin Immunol Immunopathol       Date:  1984-01

9.  Subpopulations of mononuclear cells in ageing: expansion of the null cell compartment and decrease in the number of T and B cells in human blood.

Authors:  G J Ligthart; H R Schuit; W Hijmans
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

10.  Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers.

Authors:  E Tønnesen; N J Christensen; M M Brinkløv
Journal:  Eur J Clin Invest       Date:  1987-12       Impact factor: 4.686

View more
  8 in total

1.  Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Annette N Bruchfeld; Lorraine Harper; Matthias Schaier; Michael C Venning; Patrick Hamilton; Volker Burst; Franziska Grundmann; Michel Jadoul; István Szombati; Vladimír Tesař; Mårten Segelmark; Antonia Potarca; Thomas J Schall; Pirow Bekker
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

2.  Characterization of T cells and cytokines in the aqueous humour (AH) in patients with Fuchs' heterochromic cyclitis (FHC) and idiopathic anterior uveitis (IAU).

Authors:  M Muhaya; V Calder; H M Towler; B Shaer; M McLauchlan; S Lightman
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

3.  Short-term Haematological Parameters Following Surgical Removal of Mandibular Third Molars with Different Doses of Methylprednisolone Compared with Placebo. A Randomized Controlled Trial.

Authors:  Marie Kjærgaard Larsen; Thomas Kofod; Kirsten Duch; Thomas Starch-Jensen
Journal:  J Oral Maxillofac Res       Date:  2020-06-30

4.  Neural stem cells secreting bispecific T cell engager to induce selective antiglioma activity.

Authors:  Katarzyna C Pituch; Markella Zannikou; Liliana Ilut; Ting Xiao; Michael Chastkofsky; Madina Sukhanova; Nicola Bertolino; Daniele Procissi; Christina Amidei; Craig M Horbinski; Karen S Aboody; C David James; Maciej S Lesniak; Irina V Balyasnikova
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

5.  Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.

Authors:  C Salvarani; L Boiardi; P Macchioni; F Rossi; P Tartoni; M Casadei Maldini; R Mancini; E Beltrandi; I Portioli
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

6.  Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses.

Authors:  Nils Schweingruber; Henrike J Fischer; Lisa Fischer; Jens van den Brandt; Anna Karabinskaya; Verena Labi; Andreas Villunger; Benedikt Kretzschmar; Peter Huppke; Mikael Simons; Jan P Tuckermann; Alexander Flügel; Fred Lühder; Holger M Reichardt
Journal:  Acta Neuropathol       Date:  2014-02-01       Impact factor: 17.088

7.  Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system.

Authors:  Pia M Vidal; Antigona Ulndreaj; Anna Badner; James Hong; Michael G Fehlings
Journal:  J Neuroinflammation       Date:  2018-08-06       Impact factor: 8.322

8.  Chlorambucil combination therapy in refractory serpiginous choroiditis: A cure?

Authors:  Arash Maleki; Anapatricia Maldonado Cerda; Cristina M Garcia; Mike Zein; Ambika Manhapra; C Stephen Foster
Journal:  Am J Ophthalmol Case Rep       Date:  2021-01-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.